Talphera, Inc.
- TLPH
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Specialty Pharmaceuticals
- Hospital/Clinic Anticoagulant (Niyad)
$1.08
Today +0.93%Quote Oct 16, 2026, 08:00 PM UTC
−7.69%over the last month
Max drawdown −11.8%From 1-month high −9.2%3 months −16.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$56.1M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$3.00
+177.8% from here
Floor
$1.08
0.1% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TLPHPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Drug Manufacturers - Specialty & Generic
Employees
12